0.744
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ITRM Giù?
Forum
Previsione
Frazionamento azionario
Iterum Therapeutics Plc Borsa (ITRM) Ultime notizie
Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2025 Earnings Call Transcript - MSN
Fibonacci Support Holding Strong in Iterum Therapeutics plcJuly 2025 Macro Moves & High Accuracy Buy Signal Tips - newsyoung.net
ITRM Reports Results - AOL.com
Iterum launches first oral penem antibiotic for urinary tract infections - Investing.com
Iterum Therapeutics Launches New Antibiotic ORLYNVAH - TipRanks
Iterum Therapeutics Launches ORLYNVAH™: First Oral Penem Antibiotic Approved for Uncomplicated UTIs in Over 25 Years - Quiver Quantitative
Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - MarketScreener
First-Ever Oral Penem Antibiotic: Iterum's ORLYNVAH Launches to Combat Drug-Resistant UTIs in Women - Stock Titan
How to manage a losing position in Iterum Therapeutics plcJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
Should you wait for a breakout in Iterum Therapeutics plc2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Order Flow Trends Show Accumulation in Iterum Therapeutics plcGap Up & Real-Time Buy Signal Notifications - beatles.ru
Technical analysis overview for Iterum Therapeutics plc stockBreakout Watch & Risk Controlled Swing Trade Alerts - Newser
What institutional flow reveals about Iterum Therapeutics plcJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Live market analysis of Iterum Therapeutics plcJuly 2025 Selloffs & Detailed Earnings Play Strategies - Newser
Using data filters to optimize entry into Iterum Therapeutics plcJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Exit strategy if you’re trapped in Iterum Therapeutics plcWeekly Loss Report & Low Drawdown Investment Ideas - Newser
Will Iterum Therapeutics plc continue its uptrend2025 Momentum Check & AI Enhanced Execution Alerts - Newser
Price momentum metrics for Iterum Therapeutics plc explainedMarket Growth Review & Weekly Return Optimization Alerts - Newser
Iterum Therapeutics plc Facing Inflection Point in Trend Analysis2025 Macro Impact & Reliable Price Action Trade Plans - 선데이타임즈
What’s next for Iterum Therapeutics plc stock priceJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - Newser
Using economic indicators to assess Iterum Therapeutics plc potentialMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Chart based exit strategy for Iterum Therapeutics plcEarnings Overview Report & Daily Stock Trend Reports - Newser
Is Iterum Therapeutics plc reversing from oversold territory2025 Dividend Review & Community Supported Trade Ideas - Newser
What are Iterum Therapeutics plc’s earnings expectationsTrade Entry Summary & Safe Capital Growth Trade Ideas - thegnnews.com
Intraday pattern recognizer results for Iterum Therapeutics plcBreakout Watch & Real-Time Volume Analysis Alerts - Newser
Iterum Therapeutics plc’s Price Action Aligns with Quant SignalsJuly 2025 Final Week & Risk Controlled Stock Pick Alerts - metal.it
Advanced analytics toolkit walkthrough for Iterum Therapeutics plcMarket Sentiment Summary & Breakout Confirmation Trade Signals - Newser
News impact scoring models applied to Iterum Therapeutics plcDay Trade & Technical Pattern Based Signals - Newser
Analyzing Iterum Therapeutics plc with multi timeframe charts2025 Price Targets & Entry Point Confirmation Alerts - Newser
Leading vs lagging indicators on Iterum Therapeutics plc performance2025 Fundamental Recap & Capital Protection Trading Alerts - Newser
Iterum Therapeutics plc stock trend outlook and recovery path2025 Year in Review & Weekly Top Gainers Alerts - Newser
Using Bollinger Bands to evaluate Iterum Therapeutics plc2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Iterum Therapeutics plc Reaches Critical Trendline SupportWeekly Gains Report & Comprehensive Market Scan Insights - newsyoung.net
Using Ichimoku Cloud for Iterum Therapeutics plc technicalsTrade Volume Report & Scalable Portfolio Growth Methods - Newser
Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares - Investing.com
Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares By Investing.com - Investing.com Australia
Iterum Therapeutics Director Dunne Buys 15,000 Shares at $0.72/Share on Aug 8. - AInvest
Real time pattern detection on Iterum Therapeutics plc stockSecure Buy Strategy Based on Risk Parameters - Newser
Why Iterum Therapeutics plc stock attracts strong analyst attentionLow Drawdown Picks with Weekly Updates - Newser
Developing predictive dashboards with Iterum Therapeutics plc dataFuture Growth Stock Forecasting Strategy - Newser
Will Iterum Therapeutics plc stock recover after recent dropReal Stock Picks With Setup Verification - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):